Seeing Is Believing
Analyst Chris Cooper works at GOLDMAN SACHS
Most recent stock forecast was given on RMD, ResMed at 19-Apr-2024.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
224
$36.24 (19.30%)
215
17 days ago
5/7 (71.43%)
$34.68 (18.32%)
371
Buy
215
$27.24 (14.51%)
215
22 days ago
7/11 (63.64%)
$18.67 (9.51%)
66
Buy
205
$17.24 (9.18%)
185
2 months 19 days ago
5/11 (45.45%)
$14.1 (7.39%)
88
164
$-23.76 (-12.65%)
158
2 months 24 days ago
4/6 (66.67%)
$-21.88 (-11.77%)
30
Buy
207
$19.24 (10.25%)
2 months 24 days ago
4/5 (80%)
$21.12 (11.36%)
60